The Role of the Gut Microbiota in Coronary Heart Disease Huagang LiuJunli ZhuangHongping Deng Coronary Heart Disease (S Virani and S Naderi, Section Editors) 16 October 2020 Article: 77
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention Ismail Dogu KilicEnrico FabrisCarlo Di Mario Coronary Heart Disease (S Virani and S Naderi, Section Editors) Open access 06 October 2020 Article: 76
Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications Antonio V Sterpetti Vascular Biology (J Hamilton, Section Editor) Open access 06 October 2020 Article: 75
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction Alberto ZambonAngela PirilloAlberico L. Catapano Nonstatin Drugs (M. Vrablik, Section Editor) 03 October 2020 Article: 74
State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and Limitations Priya KoilpillaiNiti R. AggarwalSharon L. Mulvagh Women and Ischemic Heart Disease (P. Kohli , Section Editor) 03 October 2020 Article: 73
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well Xiaoming JiaMahmoud Al RifaiSalim S. Virani Reviews and New Research Implications (S.Virani, Section Editor) 03 October 2020 Article: 72
Digital Health Innovations to Improve Cardiovascular Disease Care Karla SantoJulie Redfern Coronary Heart Disease (S. Virani and S. Naderi, Section Editor) 03 October 2020 Article: 71